MedPath

Loop-tipped Guidewire in Selective Biliary Cannulation

Not Applicable
Completed
Conditions
Bile Duct Cancer
Ampullary Tumor
Pancreatic Cancer
Choledocholithiasis
Registration Number
NCT02028845
Lead Sponsor
Ajou University School of Medicine
Brief Summary

1. Background

* Advanced guidewires with a U-shaped tip could effectively cross the long or multi-occlusive segment smoothly and go into the distal outflow vessel.

* The guidewire looping technique is a safe and effective method for the recanalization of the occluded lesions in infrapopliteal vessels.

2. Objective - To compare the performance a loop-tipped guidewire with a straight-tipped guidewire in achieving successful deep biliary cannulation.

3. Design

- Prospective randomized trial.

4. Setting:

- Tertiary-care medical center

5. Patients

- This study will involve 192 patients with biliary diseases which require endoscopic retrograde cholangiopancreatography.

6. Intervention - Cannulation of bile duct by using a loop-tipped guidewire or a straight-tipped guidewire

7. Main outcome measurements - Compare the cannulation success rate, the duration of the cannulation, immediate and late complications.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
200
Inclusion Criteria
  • age > 19 and ability to consent
  • no evidence of significant cardiopulmonary or medical comorbidities precluding participation
Exclusion Criteria
  • Known gastroduodenal anatomic abnormalities
  • Coagulation disorders (international normalized ratio > 1.5 or platelet count < 50000 cells/cubic millimeter)
  • Prior gastric surgery,endoscopic retrograde cholangiopancreatography
  • Pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
The cannulation success rateUp to 9 months, The primary outcome measure will be assessed after the enrollment of patients (anticipated time: 2014/08/30).
Secondary Outcome Measures
NameTimeMethod
The duration of the cannulation, immediate and late complications.Up to 9 months, The secondary outcome measure will be assessed after the enrollment of patients (anticipated time: 2014/08/30).

Trial Locations

Locations (1)

Department of Gastroenterology, Ajou University School of Medicine

🇰🇷

Suwon, Gyeonggi, Korea, Republic of

Department of Gastroenterology, Ajou University School of Medicine
🇰🇷Suwon, Gyeonggi, Korea, Republic of

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.